This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): WCK5222, WCK-5222, zidebactam and cefepime
Description: WCK 5222 (zidebactam and cefepime) is an antibiotic for gram negative infections. WCK 5222 is a new class of antibiotic being developed for complicated Urinary Tract Infections and Hospital Acquired Bacterial Pneumonia. In Q4 2015, the US FDA granted WCK 5222 Qualified Infectious Disease Product (QIDP) status.
WCK 5222 News
Additional information available to subscribers only: